These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34328710)

  • 1. Carbon Monoxide Releasing Molecule A1 Reduces Myocardial Damage After Acute Myocardial Infarction in a Porcine Model.
    Iqbal J; Chamberlain J; Alfaidi M; Hughes M; Alizadeh T; Casbolt H; Evans P; Mann B; Motterlini R; Francis S; Gunn J
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e656-e661. PubMed ID: 34328710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3).
    Filippo CD; Perretti M; Rossi F; Ferraraccio F; Motterlini R; D'Amico M
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):137-44. PubMed ID: 22038495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Techiryan G; Weil BR; Palka BA; Canty JM
    Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonocclusive multivessel intracoronary infusion of allogeneic cardiosphere-derived cells early after reperfusion prevents remote zone myocyte loss and improves global left ventricular function in swine with myocardial infarction.
    Suzuki G; Weil BR; Young RF; Fallavollita JA; Canty JM
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H345-H356. PubMed ID: 31125261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon monoxide releasing molecule improves structural and functional cardiac recovery after myocardial injury.
    Segersvärd H; Lakkisto P; Hänninen M; Forsten H; Siren J; Immonen K; Kosonen R; Sarparanta M; Laine M; Tikkanen I
    Eur J Pharmacol; 2018 Jan; 818():57-66. PubMed ID: 29055786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary Administration of Allogeneic Cardiosphere-Derived Cells Immediately Prior to Reperfusion in Pigs With Acute Myocardial Infarction Reduces Infarct Size and Attenuates Adverse Cardiac Remodeling.
    Sousonis V; Sfakianaki T; Ntalianis A; Nanas I; Kontogiannis C; Aravantinos D; Kapelios C; Katsaros L; Nana M; Sampaziotis D; Sanoudou D; Papalois A; Malliaras K
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):88-99. PubMed ID: 32677460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
    Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
    Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo.
    Guo Y; Stein AB; Wu WJ; Tan W; Zhu X; Li QH; Dawn B; Motterlini R; Bolli R
    Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1649-53. PubMed ID: 14704226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction.
    Bakhta O; Blanchard S; Guihot AL; Tamareille S; Mirebeau-Prunier D; Jeannin P; Prunier F
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):446-455. PubMed ID: 29658326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
    Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
    Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical Pre-Conditioning With Acute Circulatory Support Before Reperfusion Limits Infarct Size in Acute Myocardial Infarction.
    Kapur NK; Qiao X; Paruchuri V; Morine KJ; Syed W; Dow S; Shah N; Pandian N; Karas RH
    JACC Heart Fail; 2015 Nov; 3(11):873-82. PubMed ID: 26541785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size.
    Kapur NK; Paruchuri V; Urbano-Morales JA; Mackey EE; Daly GH; Qiao X; Pandian N; Perides G; Karas RH
    Circulation; 2013 Jul; 128(4):328-36. PubMed ID: 23766351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of remifentanil on myocardial ischemia-reperfusion injury and the expressions of Bax and Bcl-2 in rats.
    Li J; Hu HP; Li Y; Shao W; Zhang JZ; Wang LM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8951-8960. PubMed ID: 30575939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebroprotective effects of the CO-releasing molecule CORM-A1 against seizure-induced neonatal vascular injury.
    Zimmermann A; Leffler CW; Tcheranova D; Fedinec AL; Parfenova H
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2501-7. PubMed ID: 17630349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.